IL150977A - Use of protein source for preparation of a nutitional composition for maintaining or improving the synthesis of mucins - Google Patents

Use of protein source for preparation of a nutitional composition for maintaining or improving the synthesis of mucins

Info

Publication number: IL150977A
Authority: IL; Israel
Prior art keywords: mucins; synthesis; maintaining; improving; nutitional
Prior art date: 2000-02-04

Application number

IL15097701A

Other languages

English (en)

Other versions

IL150977A0 (en

Original Assignee

Nestle Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-02-04

Filing date

2001-01-31

Publication date

2005-09-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27052980&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL150977(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-01-30 Priority claimed from US09/774,814 external-priority patent/US6833350B2/en

2001-01-31 Application filed by Nestle Sa filed Critical Nestle Sa

2003-02-12 Publication of IL150977A0 publication Critical patent/IL150977A0/xx

2005-09-25 Publication of IL150977A publication Critical patent/IL150977A/xx

Links

102000015728 Mucins Human genes 0.000 title abstract 3
108010063954 Mucins Proteins 0.000 title abstract 3
230000015572 biosynthetic process Effects 0.000 title abstract 2
229940051875 mucins Drugs 0.000 title abstract 2
238000003786 synthesis reaction Methods 0.000 title abstract 2
238000002360 preparation method Methods 0.000 title 1
102000004169 proteins and genes Human genes 0.000 title 1
108090000623 proteins and genes Proteins 0.000 title 1
201000010099 disease Diseases 0.000 abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
208000035143 Bacterial infection Diseases 0.000 abstract 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 abstract 1
239000004473 Threonine Substances 0.000 abstract 1
230000004075 alteration Effects 0.000 abstract 1
208000022362 bacterial infectious disease Diseases 0.000 abstract 1
230000002757 inflammatory effect Effects 0.000 abstract 1
230000000968 intestinal effect Effects 0.000 abstract 1
235000016709 nutrition Nutrition 0.000 abstract 1
239000013589 supplement Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nutrition Science (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Mycology (AREA)
Hematology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Obesity (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Diabetes (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

IL15097701A 2000-02-04 2001-01-31 Use of protein source for preparation of a nutitional composition for maintaining or improving the synthesis of mucins IL150977A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US49890500A	2000-02-04	2000-02-04
US09/774,814 US6833350B2 (en)	2000-02-04	2001-01-30	Method for maintaining or improving the synthesis of mucins
PCT/EP2001/001013 WO2001056405A2 (fr)	2000-02-04	2001-01-31	Methode de maintien ou d'amelioration de la synthese de mucines

Publications (2)

Publication Number	Publication Date
IL150977A0 IL150977A0 (en)	2003-02-12
IL150977A true IL150977A (en)	2005-09-25

Family

ID=27052980

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL15097701A IL150977A (en)	2000-02-04	2001-01-31	Use of protein source for preparation of a nutitional composition for maintaining or improving the synthesis of mucins

Country Status (22)

Country	Link
EP (1)	EP1255452B2 (fr)
JP (1)	JP2003533436A (fr)
CN (1)	CN1434681B (fr)
AT (1)	ATE323422T1 (fr)
AU (1)	AU784137B2 (fr)
BG (1)	BG106967A (fr)
BR (1)	BRPI0108096B1 (fr)
CA (1)	CA2399063C (fr)
CZ (1)	CZ20022978A3 (fr)
DE (1)	DE60118888T3 (fr)
DZ (1)	DZ3298A1 (fr)
ES (1)	ES2261383T5 (fr)
HR (1)	HRP20020647A2 (fr)
HU (1)	HUP0204439A3 (fr)
IL (1)	IL150977A (fr)
MA (1)	MA25656A1 (fr)
MX (1)	MXPA02007491A (fr)
NO (1)	NO20023640L (fr)
NZ (1)	NZ520605A (fr)
PL (1)	PL357078A1 (fr)
SK (1)	SK11212002A3 (fr)
WO (1)	WO2001056405A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2382874A1 (fr)	2003-06-23	2011-11-02	Nestec S.A.	Supplémentation d'acides aminés pour un écosystème microbiotique sain
JPWO2007004613A1 (ja) *	2005-07-01	2009-01-29	味の素株式会社	炎症性腸疾患治療薬及びＴＮＦ−α産生抑制剤
EP1971230A2 (fr) *	2006-01-09	2008-09-24	Nestec S.A.	Traitement de patients stressés
WO2012133198A1 (fr) *	2011-03-25	2012-10-04	イーエヌ大塚製薬株式会社	Composition nutritionnelle pour maladies inflammatoires
PH12014500185A1 (en)	2011-07-22	2019-10-11	Abbott Lab	Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
EP3167895A1 (fr) *	2015-11-10	2017-05-17	University College Dublin	Complément alimentaire contenant du bêta-glucane et d'hydrolysat de caséine pour améliorer la santé et la performance de croissance chez un mammifère

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2459620B1 (fr) *	1979-06-26	1983-08-05	Agronomique Inst Nat Rech	Hydrolisat enzymatique total de proteines de lactoserum, obtention et application
US5162373A (en) *	1986-01-17	1992-11-10	Board Of Regents, The University Of Texas System	Methods and improved formulations for the determination and treatment of malignant disease in patients
JP2631470B2 (ja) *	1987-05-15	1997-07-16	雪印乳業株式会社	感染防御剤
CA1338682C (fr) *	1988-12-23	1996-10-29	Gustavo Bounous	Concentre de proteine non caseique, biologiquement actif, utile comme supplement alimentaire
JP2805490B2 (ja) *	1989-02-07	1998-09-30	雪印乳業株式会社	細菌毒素中和剤
JP3007694B2 (ja) *	1990-12-14	2000-02-07	雪印乳業株式会社	胃潰瘍予防または治療のための医薬及び飲食品
DE69331528T2 (de) *	1992-12-23	2002-10-31	Abbott Laboratories, Abbott Park	Medizinische nahrungsmittel für die ernährungsergänzung bei metabolischen erkrankungen von säuglingen/kleinkindern
NZ248605A (en) *	1993-05-28	1994-12-22	Abbott Lab	Enteral nutritional product comprising protein and fat
FR2711529B1 (fr) *	1993-10-28	1996-07-05	Clintec Nutrition Cy	Composition à base d'acides aminés destinée au traitement d'une infection ou d'une agression engendrant une réaction inflammatoire, chez les animaux et chez l'homme.
JPH07267855A (ja) *	1994-03-30	1995-10-17	Taiho Yakuhin Kogyo Kk	グルタミン産生剤
US5952314A (en) *	1994-04-01	1999-09-14	Demichele; Stephen Joseph	Nutritional product for a person having ulcerative colitis
US5728678A (en) *	1995-06-06	1998-03-17	Nestec Ltd.	Method and composition for providing nutrition to a renal failure patient
US5670157A (en) *	1995-12-11	1997-09-23	Nestec Ltd.	Method for reducing and controlling immunoglobulin concentrations
US5922766A (en) *	1997-07-02	1999-07-13	Acosta; Phyllis J. B.	Palatable elemental medical food
WO1999013738A1 (fr) *	1997-09-16	1999-03-25	Societe Des Produits Nestle S.A.	Alimentation specifique a un organe
CA2331921A1 (fr) *	1998-06-24	1999-12-29	Boyce Thompson Institute For Plant Research, Inc.	Nouvel adnc mucin intestinal des invertebres et produits et procedes correspondants
EP1034704A1 (fr) *	1999-03-12	2000-09-13	Societe Des Produits Nestle S.A.	Composition nutritionnelle notamment pour la maturation gastro-intestinale spécifique dans des mammifères prématurés
CA2387907A1 (fr) *	1999-10-22	2001-05-03	The Board Of Regents Of The University Of Nebraska	Isoforme de serum amyloide a decouverte dans le colostrum

2001
- 2001-01-31 HU HU0204439A patent/HUP0204439A3/hu unknown
- 2001-01-31 AT AT01911559T patent/ATE323422T1/de not_active IP Right Cessation
- 2001-01-31 DE DE60118888T patent/DE60118888T3/de not_active Expired - Lifetime
- 2001-01-31 CA CA2399063A patent/CA2399063C/fr not_active Expired - Lifetime
- 2001-01-31 AU AU40564/01A patent/AU784137B2/en not_active Ceased
- 2001-01-31 DZ DZ013298A patent/DZ3298A1/fr active
- 2001-01-31 MX MXPA02007491A patent/MXPA02007491A/es unknown
- 2001-01-31 NZ NZ520605A patent/NZ520605A/en unknown
- 2001-01-31 BR BRPI0108096A patent/BRPI0108096B1/pt active IP Right Grant
- 2001-01-31 HR HRP20020647 patent/HRP20020647A2/hr not_active Application Discontinuation
- 2001-01-31 WO PCT/EP2001/001013 patent/WO2001056405A2/fr not_active Ceased
- 2001-01-31 EP EP01911559A patent/EP1255452B2/fr not_active Expired - Lifetime
- 2001-01-31 JP JP2001556111A patent/JP2003533436A/ja active Pending
- 2001-01-31 PL PL01357078A patent/PL357078A1/xx not_active Application Discontinuation
- 2001-01-31 CN CN018074375A patent/CN1434681B/zh not_active Expired - Lifetime
- 2001-01-31 ES ES01911559T patent/ES2261383T5/es not_active Expired - Lifetime
- 2001-01-31 SK SK1121-2002A patent/SK11212002A3/sk unknown
- 2001-01-31 CZ CZ20022978A patent/CZ20022978A3/cs unknown
- 2001-01-31 IL IL15097701A patent/IL150977A/xx not_active IP Right Cessation
2002
- 2002-07-31 NO NO20023640A patent/NO20023640L/no unknown
- 2002-07-31 BG BG106967A patent/BG106967A/bg unknown
- 2002-08-30 MA MA26798A patent/MA25656A1/fr unknown

Also Published As

Publication number	Publication date
JP2003533436A (ja)	2003-11-11
CA2399063A1 (fr)	2001-08-09
ES2261383T3 (es)	2010-06-14
PL357078A1 (en)	2004-07-12
BG106967A (bg)	2003-04-30
DE60118888T3 (de)	2010-09-23
HUP0204439A2 (hu)	2003-04-28
AU4056401A (en)	2001-08-14
CN1434681A (zh)	2003-08-06
BRPI0108096B1 (pt)	2017-05-09
NO20023640L (no)	2002-09-19
MA25656A1 (fr)	2002-12-31
ATE323422T1 (de)	2006-05-15
NZ520605A (en)	2004-06-25
EP1255452B1 (fr)	2006-04-19
ES2261383T5 (es)	2010-06-18
CA2399063C (fr)	2014-01-28
HUP0204439A3 (en)	2004-12-28
HRP20020647A2 (en)	2004-12-31
WO2001056405A3 (fr)	2002-01-24
CZ20022978A3 (cs)	2003-02-12
DZ3298A1 (fr)	2001-08-09
EP1255452A2 (fr)	2002-11-13
SK11212002A3 (sk)	2003-01-09
EP1255452B2 (fr)	2010-03-03
MXPA02007491A (es)	2002-12-13
NO20023640D0 (no)	2002-07-31
DE60118888T2 (de)	2007-01-18
DE60118888D1 (de)	2006-05-24
IL150977A0 (en)	2003-02-12
WO2001056405A2 (fr)	2001-08-09
AU784137B2 (en)	2006-02-09
BR0108096A (pt)	2002-10-29
CN1434681B (zh)	2010-12-08

Legal Events

Date	Code	Title
2006-06-18	KB	Patent renewed
2007-05-21	KB	Patent renewed
2011-09-27	MM9K	Patent not in force due to non-payment of renewal fees

Publication	Publication Date	Title
WO2000053758A3 (fr)	2001-02-08	Compositions et methodes de traitement des maladies immunitaires
MXPA05009933A (es)	2005-11-04	Composiciones que comprenden acidos grasos y aminoacidos.
WO2004024068A3 (fr)	2005-02-10	Nouvelles composition et methodes servant au traitement de maladies associees au systeme immunitaire
MXPA05013815A (es)	2006-03-13	Uso de isomalt (mezcla de 1, 6 gps y 1,1 gpm) como prebiotico para la produccion de un medicamento usado en el tratamiento de enfermedades intestinales, entre otras cosas.
MY139124A (en)	2009-08-28	Gyrase inhibitors and uses thereof
EP2322203A3 (fr)	2011-07-27	Les compositions et les methodes pour le traitement de maladies liees immunisees
EP2182006A3 (fr)	2010-09-15	Compositions et procédés pour le traitement de maladies liées au système immunitaire
IL147271A0 (en)	2002-08-14	Compounds that bind her2
BR0214705A (pt)	2004-11-23	Composição, seu uso, método para prevenção ou tratamento de doença neurodegenerativa, e kit
EP1487273A4 (fr)	2006-07-12	Compositions et methodes de traitement d'infections microbiennes
WO2005103084A3 (fr)	2006-02-16	Peptides de liaison a poly-n-acetyl glucosamine (pnag/dpnag) et leurs procedes d'utilisation
MY138708A (en)	2009-07-31	Biaryloxymethylarenecarboxylic acids
CA2396865A1 (fr)	2001-08-09	Inhibiteurs de la farnesyl proteine transferase pour le traitement du cancer du sein
MXPA03011546A (es)	2004-03-19	Formulacion farmaceutica.
IL153680A0 (en)	2003-07-06	Aplidine derivatives and methods for the preparation thereof
WO2005037839A8 (fr)	2005-07-07	Composes derives de norcantharidine, leurs procedes de preparation, les compositions les contenant et leurs utilisations.
JO2795B1 (en)	2014-03-15	Immunoglobulins
AU4011300A (en)	2001-02-05	Compositions and methods for the treatment of immune related diseases
WO2004024072A3 (fr)	2006-03-16	Nouvelles compositions et methodes pour le traitement de maladies associees au systeme immunitaire
BRPI0409609A (pt)	2006-04-18	mediadores do transporte reverso de colesterol para o tratamento da hipercolesterolemia
IL150977A (en)	2005-09-25	Use of protein source for preparation of a nutitional composition for maintaining or improving the synthesis of mucins
IL113940A0 (en)	1995-08-31	Novel elastase inhibitors
WO2004081199A3 (fr)	2005-06-16	Nouvelles compositions et methodes de traitement de troubles du systeme immunitaire
YU58102A (sh)	2004-12-31	Postupak za održavanje ili poboljšanje sinteze mucina
MXPA04001986A (es)	2004-06-07	Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad.